| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | — |
| Cost of Revenue | $9.7M | — |
| R&D Expense | $69.3M | -21.8% |
| SG&A Expense | $31.2M | +20.8% |
| Operating Income | -$108.1M | +5.5% |
| Pre-tax Income | -$40.8M | — |
| Income Tax | $0 | — |
| Net Income | -$40.8M | +72.5% |
| EPS (Basic) | -$0.26 | +79.4% |
| EPS (Diluted) | -$0.26 | +79.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.5M | +12.4% |
| Accounts Receivable | $441K | +145.0% |
| Inventory | $13.6M | — |
| Current Assets | $67.8M | +41.7% |
| Total Assets | $116.4M | -15.6% |
| Current Liabilities | $18.4M | -7.9% |
| Long-term Debt | $35.4M | — |
| Total Liabilities | $113.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$105.0M | -7.1% |
| Capital Expenditures | $884K | -43.8% |
| Investing Cash Flow | -$884K | +43.8% |
| Financing Cash Flow | $61.5M | -46.2% |
| Free Cash Flow | -$105.9M | -6.3% |
| -40.6% |
| Stockholders' Equity | $3.1M | +105.9% |